You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tablet

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Glendale (Y-2 Sublingual Tablet, Placebo)

Not yet recruiting
  • Healthy
  • Y-2 Sublingual Tablet
  • Placebo
  • Glendale, California
    Parexel International Los Angeles Early Phase Clinical Unit
Jul 10, 2023

Healthy Volunteer Trial (Lumacaftor 200 mg/Ivacaftor 125 mg Film-Coated Tablet, Lumacaftor 200 mg Film-Coated Tablet

Not yet recruiting
  • Healthy Volunteer
  • Lumacaftor 200 mg/Ivacaftor 125 mg Film-Coated Tablet
  • Lumacaftor 200 mg Film-Coated Tablet Formulation
  • (no location specified)
Jul 21, 2023

Healthy Participants Trial (Single dose of PF-07220060 as first Tablet Formulation, Single dose of PF-07220060 as second Tablet

Not yet recruiting
  • Healthy Participants
  • Single dose of PF-07220060 as first Tablet Formulation
  • +3 more
  • (no location specified)
Jun 20, 2023

Dyslipidemia Trial in Seoul (Rosuvastatin Immediate-Release Tablet (IRT) 10mg, Rosuvastatin orally disintegrating tablet

Recruiting
  • Dyslipidemia
  • Rosuvastatin Immediate-Release Tablet (IRT) 10mg
  • Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg
  • Seoul, Korea, Republic of
    Division of Cardiology, Department of Internal Medicine, Yonsei
Nov 22, 2023

Bioavailability Trial in Montréal (Filgotinib)

Not yet recruiting
  • Bioavailability
  • Montréal, Canada
    Altasciences
Sep 12, 2023

Healthy Trial in Shanghai (Sudapyridine 30mg, Sudapyridine 100mg SAD, Sudapyridine 200mg SAD)

Completed
  • Healthy
  • Sudapyridine 30mg
  • +7 more
  • Shanghai, China
    Shanghai Xuhui District Central Hospital
Nov 2, 2023

Healthy Volunteers Trial (BMS-986419 DR Capsule, BMS-986419 IR Tablet)

Not yet recruiting
  • Healthy Volunteers
  • BMS-986419 DR Capsule
  • BMS-986419 IR Tablet
  • (no location specified)
Jul 20, 2023

Fibromyalgia Syndrome Trial (Tongluo-Kaibi tablet plus of pregabalin, of Tongluo-Kaibi tablet plus pregabalin)

Not yet recruiting
  • Fibromyalgia Syndrome
  • Tongluo-Kaibi tablet plus placebo of pregabalin
  • placebo of Tongluo-Kaibi tablet plus pregabalin
  • (no location specified)
Jun 28, 2023

Diarrhea-Predominant Irritable Bowel Syndrome Trial (Changyanning tablet, Changyanning tablet )

Not yet recruiting
  • Diarrhea-Predominant Irritable Bowel Syndrome
  • Changyanning tablet
  • Changyanning tablet placebo
  • (no location specified)
Jan 13, 2023

Healthy Trial in Jakarta (Dapagliflozin 10 mg film-coated tablet, Forxiga® 10 mg Film-Coated Tablet, manufactured by AstraZeneca

Completed
  • Healthy
  • Dapagliflozin 10 mg film-coated tablet
  • Forxiga® 10 mg Film-Coated Tablet, manufactured by AstraZeneca Pharmaceuticals LP, USA for AstraZeneca Pharmaceuticals Co. Ltd., China imported by PT AstraZeneca Indonesia, Indonesia
  • Jakarta, Indonesia
    PT Equilab International
Nov 7, 2023

Healthy Individuals Trial in Karachi (Test Drug, Reference Drug)

Recruiting
  • Healthy Individuals
  • Test Drug
  • Reference Drug
  • Karachi, Sindh, Pakistan
    Muhammad Raza Shah
Dec 18, 2022

Focal Segmental Glomerulosclerosis (FSGS) Trial (VX-147)

Not yet recruiting
  • Focal Segmental Glomerulosclerosis (FSGS)
  • (no location specified)
Jul 13, 2023

Hypertension Trial in Cincinnati (baxdrostat (formerly CIN-107) oral solution)

Completed
  • Hypertension
  • baxdrostat (formerly CIN-107) oral solution
  • Cincinnati, Ohio
    Medpace
Jul 18, 2023

Malaria Trial in Arzo (pyronaridine artesunate)

Completed
Has Results
  • Malaria
  • pyronaridine artesunate clinical trial reference tablets
  • pyronaridine artesunate to-be-marketed tablets
  • Arzo, Switzerland
    Cross Research S.A., Phase I Unit
Feb 1, 2023

Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet

Recruiting
  • Gastroesophageal Reflux Disease
  • Fexuprazan Hydrochloride
  • Busan, Korea, Republic of
    Co&Ping Otolaryngology Clinic
May 24, 2023

A Study to Evaluate the Efficacy and Safety of CREZET Tablet

Recruiting
  • Dyslipidemias
  • Busan, Korea, Republic of
    Kimyounggi Clinic
May 25, 2023

Leukemia, Myelogenous, Chronic Trial in Changchun (CTTQ Dasatinib tablet, Sprycel Dasatinib tablet)

Completed
  • Leukemia, Myelogenous, Chronic
  • CTTQ Dasatinib tablet
  • Sprycel Dasatinib tablet
  • Changchun, Jilin, China
    Affiliated Hospital of Changchun University of Traditional Chine
Dec 7, 2022

Healthy Trial in Seoul (JP-1366 20mg tablet)

Not yet recruiting
  • Healthy
  • JP-1366 20mg tablet
  • Seoul, Korea, Republic of
    Asan Medical Central
Jan 25, 2023

Migraine Trial in Tanta (zolmitriptanee, topiramate, Valproate)

Recruiting
  • Migraine
  • Tanta, Kafrelsheikh, Egypt
    Kafrelsheikh University
Oct 13, 2023

Healthy Trial in Seoul (Acetaminophen)

Completed
  • Healthy
  • Seoul, Korea, Republic of
    H plus Yangji Hospital
Jan 3, 2023

Chronic Coronary Syndrome Trial in China (Yangxinshi tablet, Yangxinshi tablet simulants)

Not yet recruiting
  • Chronic Coronary Syndrome
  • Yangxinshi tablet
  • Yangxinshi tablet simulants
  • Beijing, Beijing, China
  • +5 more
Aug 3, 2023

Healthy Participants Trial in Ruddington (ALXN2050 MR Prototype Tablet, ALXN2050 Immediate Release (IR) Tablet, ALXN2050 MR

Not yet recruiting
  • Healthy Participants
  • ALXN2050 MR Prototype Tablet
  • +2 more
  • Ruddington, Nottinghamshire, United Kingdom
    Quotient Science Ltd
Mar 13, 2023

Amyotrophic Lateral Sclerosis (Healthy Volunteers) Trial in Saint Paul (SAR443820)

Completed
  • Amyotrophic Lateral Sclerosis (Healthy Volunteers)
  • Saint Paul, Minnesota
    Prism Research-Site Number:8400001
Mar 22, 2023

Healthy Subjects Trial in Qingdao (XZP-3621 tablet and itraconazole oral liquid (for Arm1), XZP-3621 tablet and Rifampicin

Not yet recruiting
  • Healthy Subjects
  • XZP-3621 tablet and itraconazole oral liquid (for Arm1)
  • +2 more
  • Qingdao, Shan Dong, China
    The Affiliated Hospital of Qingdao University
Oct 16, 2022

Safety of Envlo Tablet in Type II Diabetes Mellitus

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • (no location specified)
Jun 22, 2023